RESEARCH-USE BIOSIMILAR ANTIBODY
Otilimab
Monoclonal antibody · IgG1
Otilimab (GSK 3196165) is an anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) human monoclonal antibody. Otilimab neutralises the biological function of GM-CSF by blocking the interaction of GM-CSF with its cell surface receptor.
TARGETCSF2
YMonoclonal antibody
CATALOGSC-BS-298
CATALOG NUMBERSC-BS-298
MOLECULAR WEIGHTApprox. 142.22 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Otilimab (GSK 3196165) is an anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) human monoclonal antibody. Otilimab neutralises the biological function of GM-CSF by blocking the interaction of GM-CSF with its cell surface receptor.
Otilimab is a recombinant research-use antibody directed against CSF2.